Relief Therapeutics Holding SA (OTCMKTS:RLFTF – Get Free Report)’s share price traded up 8.5% during mid-day trading on Monday . The company traded as high as $2.95 and last traded at $2.93. 2,036 shares traded hands during trading, a decline of 40% from the average session volume of 3,374 shares. The stock had previously closed at $2.70.
Relief Therapeutics Price Performance
The stock’s 50-day moving average is $3.48 and its 200 day moving average is $3.32.
Relief Therapeutics Company Profile
Relief Therapeutics AG is a clinical‐stage biopharmaceutical company focused on the development of novel therapies for rare and critical care indications. Headquartered in Geneva, Switzerland, the company leverages its expertise in peptide biology to address diseases with high unmet need, including acute respiratory distress syndrome (ARDS) and other serious pulmonary and inflammatory conditions.
The company’s lead product candidate, RLF‐100 (aviptadil), is a synthetic formulation of vasoactive intestinal peptide (VIP) being evaluated for the treatment of ARDS and COVID-19–associated respiratory failure.
Further Reading
- Five stocks we like better than Relief Therapeutics
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Can Any Expenses Be Deducted From Capital Gains Tax?
- The Last Gold Bull Market
Receive News & Ratings for Relief Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relief Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
